Back to Our Team

Meghan Reynolds

Chief of Staff
Ms. Reynolds has worked in business operations and administrative support roles for over a dozen years. She began her professional career in the financial services industry, as an Investor Relations Associate for long/short hedge fund Indus Capital Partners and later in client services for investment firm Perella Weinberg Partners. Thereafter, she transitioned to the life sciences, serving as the Executive Assistant to the CEO of a small biotechnology start up, which piqued her interest in the drug discovery and development process. Meghan has been with Bantam Pharmaceutical since the inception in 2015. As Chief of Staff, she supports the C-suite and scientific team, oversees business operations and finance, and is involved in the project management of BTM-3566.

Ms. Reynolds graduated summa cum laude from Southern Connecticut State University with a Bachelor of Science in Business Administration.
We are an early mover in the field of mitochondrial homeostasis, using our pioneering science and unrivaled expertise in mitochondrial cellular biology to revolutionize oncology
We are seeking partners and additional investors to accelerate our clinical research and help bring novel cancer therapies closer to patients in need
Find Out More
Bantam is seeking partners and investors to drive rapid clinical development of our first-in-class molecule from First in Humans trials to clinical Proof of Concept.
Top linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram